article thumbnail

DEA Extends COVID-19 Telemedicine Flexibilities for Prescribing Controlled Medications for 6 Months

HIT Consultant

What You Should Know: Today, the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) issued the “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” – a temporary rule that extends telemedicine flexibilities adopted during the COVID-19 public (..)

article thumbnail

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

HIT Consultant

– The strategic collaborative effort, aligned with the HHS Roadmap for Behavioral Health Integration and the President’s call to action on mental health and substance abuse, aims to bridge the existing gap between behavioral health and physical healthcare IT systems.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

DEA officially extends remote EPCS flexibilities for 6 months

Healthcare IT News - Telehealth

This week, the DEA added some specificity to that promise – allowing an extension of six months, through November 11, 2023, and, in tandem with HHS' Substance Abuse and Mental Health Services Administration, promising a grace period for virtual prescribing of certain controlled medications to last at least until November 2024.

article thumbnail

Prior Authorization Insurance Requirements: A Barrier to Accessing Lifesaving Treatment for Opioid Use Disorder?

Bill of Health

For example, prescribers of buprenorphine must obtain a waiver from the Substance Abuse and Mental Health Services Administration (SAMHSA) prior to writing prescriptions to treat OUD, and those practitioners who wish to treat more than 30 patients are mandated to undertake training.

Medicaid 246
article thumbnail

Tele-Prescribing Flexibilities Extended Again in Second Temporary Rule

Healthcare Law Blog

This month, the Drug Enforcement Administration (“DEA”), in conjunction with the Substance Abuse and Mental Health Services Administration (“SAMHSA”), issued a Second Temporary Rule further extending the telemedicine waivers of the Ryan Haight Act (“RHA”) promulgated during the COVID-19 Public Health Emergency (“PHE”) from November 11, 2023 until December (..)

article thumbnail

Bicycle Health, Wellpath to Provide Opioid Use Disorder Treatment to Federal Bureau of Prisons

HIT Consultant

The Substance Abuse and Mental Health Services Administration has found that MOUD treatment regimens are significantly underutilized in criminal justice settings. The primary goal of this collaboration is to improve availability and clinically appropriate utilization of MOUD among this underserved patient population.

article thumbnail

DEA Chopping Block: DATA-Waiver Requirement

Healthcare Law Today

On January 12, 2023, the Drug Enforcement Administration (DEA) confirmed in a letter to registrants that the Consolidated Appropriations Act of 2023 (P.L. The Substance Abuse and Mental Health Services Administration (SAMHSA) also issued a statement on its website on the removal of the DATA-Waiver. What this Means.

COVID-19 114